Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
18.80
+0.75 (4.16%)
Nov 22, 2024, 4:00 PM EST - Market closed
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $665.62 million as of November 22, 2024. Its market cap has increased by 17.53% in one year.
Market Cap
665.62M
Enterprise Value
277.59M
1-Year Change
17.53%
Ranking
Category
Stock Price
$18.80
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has increased from $251.01M to $665.62M, an increase of 165.17%. That is a compound annual growth rate of 37.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 634.82M | 26.20% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tectonic Therapeutic | 646.98M |
| CorMedix | 646.21M |
| Exscientia | 633.50M |
| Definitive Healthcare | 632.83M |
| EyePoint Pharmaceuticals | 631.09M |
| Varex Imaging | 629.15M |
| Oculis Holding AG | 624.77M |
| InnovAge Holding | 620.39M |